GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Adbiotech Co Ltd (XKRX:179530) » Definitions » YoY EBITDA Growth

Adbiotech Co (XKRX:179530) YoY EBITDA Growth : -1,450.65% (As of Mar. 2024)


View and export this data going back to 2019. Start your Free Trial

What is Adbiotech Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Adbiotech Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 was -1,450.65%.

Adbiotech Co's EBITDA per Share for the three months ended in Mar. 2024 was ₩-455.82.


Adbiotech Co YoY EBITDA Growth Historical Data

The historical data trend for Adbiotech Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Adbiotech Co YoY EBITDA Growth Chart

Adbiotech Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
YoY EBITDA Growth
- -102.12 52.54 282.48 -209.80

Adbiotech Co Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY EBITDA Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 52.81 92.08 -1,196.34 -150.50 -1,450.65

Adbiotech Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Adbiotech Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY EBITDA Growth (A: Dec. 2023 )
=(EBITDA per Share (A: Dec. 2023 )-EBITDA per Share (A: Dec. 2022 ))/ | EBITDA per Share (A: Dec. 2022 ) |
=(-426.044-388.033)/ | 388.033 |
=-209.80 %

Adbiotech Co's YoY EBITDA Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY EBITDA Growth (Q: Mar. 2024 )
=(EBITDA per Share (Q: Mar. 2024 )-EBITDA per Share (Q: Mar. 2023 )) / | EBITDA per Share (Q: Mar. 2023 )) |
=(-455.815--29.395)/ | -29.395 |
=-1,450.65 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Adbiotech Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Adbiotech Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.


Adbiotech Co (XKRX:179530) Business Description

Traded in Other Exchanges
N/A
Address
39, Geodudanji 1-gil, Dongnae-myeon, Gangwon-do, Chuncheon, KOR, 24398
Adbiotech Co Ltd is a life science company. It develops a vaccine and antibiotic-friendly substances such as IgY, Immunoglobulin in Yolk for human, animal and fish oral antibody products, and functional cosmetics and food additives. The company aim to develop Helico IgY, Cholesterol IgY, and Ulcerative Colitis natural product medicines.

Adbiotech Co (XKRX:179530) Headlines

No Headlines